Channing Capital Management, LLC Pfizer Inc Transaction History

Channing Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 24, 2018	SELL	$31.91 - $37.02 $6.79 Million - $7.88 Million	-212,907 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $175,147 - $185,837	-5,266 Reduced 2.41%	212,907 $7.71 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $6.76 Million - $7.45 Million	218,173	218,173 $7.79 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Channing Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Channing Capital Management, LLC with notifications on news.